Search research articles
Contact Us
Filters
Showing results (21-30 of 152) with videos related to
Page
of 16
Sort By:
Expert Opinion on Drug Discovery
|
July 25, 2012
In vivo models of cardiac diseases: application to drug development and screening
Hirofumi Rokutan, Stefan D Anker, Jochen Springer
International Journal of Cardiology
|
September 11, 2014
Muscle wasting: an overview of recent developments in basic research
Sandra Palus, Stephan von Haehling, Jochen Springer
Expert Opinion on Drug Discovery
|
February 14, 2020
Promising models for cancer-induced cachexia drug discovery
Tsuyoshi Suzuki, Stephan Von Haehling, Jochen Springer
Circulation. Heart Failure
|
March 18, 2010
Adiponectin resistance in heart failure and the emerging pattern of metabolic failure in chronic heart failure
Jochen Springer, Stefan D Anker, Wolfram Doehner
International Journal of Cardiology
|
September 1, 2016
Significance of animal models of cardiac cachexia and impact of gender on cardiac cachexia
Junichi Ishida, Masaaki Konishi, Masakazu Saitoh, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
December 18, 2015
Concern regarding quality and quality of muscle
Masakazu Saitoh, Junichi Ishida, Masaaki Konishi, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
December 19, 2020
Blocking myostatin: muscle mass equals muscle strength?
Markus S Anker, Stephan von Haehling, Jochen Springer
International Journal of Cardiology
|
November 6, 2012
Liver metabolism in cardiac cachexia
Jochen Springer, Stepan von Haehling, Stefan D Anker
International Journal of Cardiology
|
October 17, 2015
Loss of muscle mass: Current developments in cachexia and sarcopenia focused on biomarkers and treatment
Cathleen Drescher, Masaaki Konishi, Nicole Ebner, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
August 6, 2016
Growth differentiation factor-15 as a prognostic biomarker in cancer patients
Junichi Ishida, Masaaki Konishi, Masakazu Saitoh, et al.
Page
of 16
Search research articles
Search
Showing results (21-30 of 152) with videos related to
Sort By:
Page
of 16
Expert Opinion on Drug Discovery
|
July 25, 2012
In vivo models of cardiac diseases: application to drug development and screening
Hirofumi Rokutan, Stefan D Anker, Jochen Springer
International Journal of Cardiology
|
September 11, 2014
Muscle wasting: an overview of recent developments in basic research
Sandra Palus, Stephan von Haehling, Jochen Springer
Expert Opinion on Drug Discovery
|
February 14, 2020
Promising models for cancer-induced cachexia drug discovery
Tsuyoshi Suzuki, Stephan Von Haehling, Jochen Springer
Circulation. Heart Failure
|
March 18, 2010
Adiponectin resistance in heart failure and the emerging pattern of metabolic failure in chronic heart failure
Jochen Springer, Stefan D Anker, Wolfram Doehner
International Journal of Cardiology
|
September 1, 2016
Significance of animal models of cardiac cachexia and impact of gender on cardiac cachexia
Junichi Ishida, Masaaki Konishi, Masakazu Saitoh, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
December 18, 2015
Concern regarding quality and quality of muscle
Masakazu Saitoh, Junichi Ishida, Masaaki Konishi, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
December 19, 2020
Blocking myostatin: muscle mass equals muscle strength?
Markus S Anker, Stephan von Haehling, Jochen Springer
International Journal of Cardiology
|
November 6, 2012
Liver metabolism in cardiac cachexia
Jochen Springer, Stepan von Haehling, Stefan D Anker
International Journal of Cardiology
|
October 17, 2015
Loss of muscle mass: Current developments in cachexia and sarcopenia focused on biomarkers and treatment
Cathleen Drescher, Masaaki Konishi, Nicole Ebner, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
August 6, 2016
Growth differentiation factor-15 as a prognostic biomarker in cancer patients
Junichi Ishida, Masaaki Konishi, Masakazu Saitoh, et al.
Page
of 16